Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · IEX Real-Time Price · USD
3.170
-0.240 (-7.04%)
At close: Apr 24, 2024, 4:00 PM
3.150
-0.020 (-0.63%)
After-hours: Apr 24, 2024, 7:59 PM EDT
Abeona Therapeutics Market Cap
Abeona Therapeutics has a market cap or net worth of $86.72 million as of April 24, 2024. Its market cap has increased by 63.31% in one year.
Market Cap
86.72M
Enterprise Value
39.55M
1-Year Change
63.31%
Ranking
Category
Stock Price
$3.17
Market Cap Chart
Since March 30, 2000, Abeona Therapeutics's market cap has increased from $78.00M to $86.72M, an increase of 11.17%. That is a compound annual growth rate of 0.44%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 23, 2024 | 93.30M | -53.65% |
Apr 22, 2024 | 201.30M | -2.80% |
Apr 19, 2024 | 207.10M | 0.53% |
Apr 18, 2024 | 206.00M | -5.03% |
Apr 17, 2024 | 216.90M | 2.17% |
Apr 16, 2024 | 212.30M | 1.58% |
Apr 15, 2024 | 209.00M | 1.21% |
Apr 12, 2024 | 206.50M | -3.10% |
Apr 11, 2024 | 213.10M | 5.86% |
Apr 10, 2024 | 201.30M | -1.08% |
Apr 9, 2024 | 203.50M | -1.07% |
Apr 8, 2024 | 205.70M | 1.08% |
Apr 5, 2024 | 203.50M | -3.37% |
Apr 4, 2024 | 210.60M | -4.36% |
Apr 3, 2024 | 220.20M | 7.62% |
Apr 2, 2024 | 204.60M | -3.13% |
Apr 1, 2024 | 211.20M | 6.51% |
Mar 28, 2024 | 198.30M | -1.25% |
Mar 27, 2024 | 200.80M | -0.25% |
Mar 26, 2024 | 201.30M | -0.54% |
Mar 25, 2024 | 202.40M | -2.79% |
Mar 22, 2024 | 208.20M | 1.07% |
Mar 21, 2024 | 206.00M | - |
Mar 20, 2024 | 206.00M | -0.53% |
Mar 19, 2024 | 207.10M | 8.32% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SELLAS Life Sciences Group | 87.78M |
Curis | 87.73M |
PMV Pharmaceuticals | 87.45M |
PetMed Express | 87.45M |
Protalix BioTherapeutics | 87.30M |
Atara Biotherapeutics | 86.26M |
Allurion Technologies | 86.13M |
Gritstone bio | 85.23M |